MTERFD 1 Functions As an Oncogene
Chaoxiong Zhang,Ning Wu,Fu Gao,Jiaqi Han,Yanyong Yang,Chuanfeng Zhou,Weimin Sun,Linfeng Xian,Ying Cheng,Bailong Li,Jianming Cai,Cong Liu
DOI: https://doi.org/10.18632/oncotarget.11140
2016-01-01
Oncotarget
Abstract:// Chaoxiong Zhang 1, 2, * , Ning Wu 3, * , Fu Gao 1, * , Jiaqi Han 1 , Yanyong Yang 1 , Chuanfeng Zhou 1 , Weimin Sun 4 , Linfeng Xian 1 , Ying Cheng 1 , Bailong Li 1 , Jianming Cai 1 , Cong Liu 1 1 Department of Radiation Medicine, Faculty of Naval Medicine, Second Military Medical University, Shanghai, 200433, PR China 2 Institute of Military Medicine, Chengdu Military Region, Chengdu, 610021, China 3 Department of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China 4 Department of Immunology, Second Military Medical University, Shanghai, 200433, People’s Republic of China * These authors contributed equally to this work Correspondence to: Jianming Cai, email: caijianming882003@163.com Cong Liu, email: victorliu20102020@163.com Keywords: MTERFD1, cancers, prognosis, proliferation, survival Received: October 02, 2015 Accepted: June 16, 2016 Published: August 09, 2016 ABSTRACT MTERFD1, also named MTERF3 (mitochondrial transcription termination factor 3), regulates transcription of the mitochondrial genome. MTERFD1 is a mitochondrial protein that represses mammalian mitochondrial DNA initiation in vivo . In this study, we found that MTERFD1 gene amplification and high expression existed in many different types of cancer. Significantly, increased expression of MTERFD1 gene was correlated with lower overall survival rate in clinical. Overexpression of MTERFD1 gene promoted to tumor cell growth in vivo and in vitro and increased the percentage of cells in S phase. In conclusion, our data firstly indicated the MTERFD1 was an oncogene in many types of cancer.